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Glossary 
 DIA, data-independent acquisition. Otherwise known as “SWATH”, a technique to acquire 
mass spectrometry data in pre-defined m/z windows across an entire LC-MS/MS analysis for 
consistent quantitation across many samples. 
 Differential centrifugation. A separation of particles based on size and density using several 
steps of pelleting by centrifugation at increasing g-force. 
 Equilibrium gradient centrifugation. A separation of particles based upon density, usually 
using a gradient of either sucrose, iodixanol, or caesium chloride. Samples are applied to the 
top of the gradient and a large centrifugal force applied until the particles reach equilibrium at 
the point in the gradient of the same density as their own. 
 Non-equilibrium gradient centrifugation. Similar to “Equilibrium gradient centrifugation” but 
the application of centrifugal force is stopped before the particles reach equilibrium. 
 Protein correlation profiling. The clustering of protein profiles to predict components in a 
particular protein complex or cellular localisation. Usually this is based upon proteomic 
analysis of cellular organelles or protein complexes fractionated using techniques such as 
chromatography or centrifugation. 
 ERAD, endoplasmic-reticulum (ER)-associated protein degradation. A proteasome-dependent 
protein degradation pathway for the destruction of ER proteins. 
 ‘Click’ (reaction). A cycloaddition reaction, particularly between an azide and alkyne, 
involving chemical groups that are not found in nature. The incorporation into cellular 
proteins of a probe of interest containing either an azide, or alkyne group, allows subsequent 
specific labelling of the probe with a tag such as a biotin molecule or fluorescent dye via the 
cycloaddition reaction. 
 SRM, selected reaction monitoring. A mass-spectrometry method used to focus the instrument 
on a specific fragment ion derived from a peptide ion of interest. Methods can be generated to 
analyse many fragment ions from the same peptide and many peptide ion precursors in a 
single LC-MS/MS analysis. 
 MS3, third-stage tandem mass spectrum. Acquired after fragmentation of isolated peptide 
fragments from a MS2 analysis. 
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 PTM. Post-translational modification of proteins due to either enzymatic, or chemical 
reactions altering the structure of amino acids after protein synthesis. 
 Label-free quantitation. The quantitation of proteins using data derived either from the number 
of MS/MS spectra, the number of peptides identified and/or the intensity of each peptide 
observed. These values can be normalised and combined in various ways, for example, taking 
into account protein size and the number of peptides that could theoretically be observed. 
These techniques involve no exogenous stable isotope labelling.  
 LC-MS/MS, liquid chromatography coupled online to tandem mass spectrometry. Standard 
approach for bottom-up proteome analysis of peptides. Usually uses nano-flow reverse-phase 
chromatography coupled to an electrospray ionisation source and a mass spectrometer capable 
of multiple rounds of isolation, fragmentation and mass spectrum acquisition. 
 LIMS, laboratory information management system. A database to store experimental data and 
associated metadata, typically including details of experimental design. 
 
Online Summary 
 The proteome is complex due to the array of properties each protein may display and the 
constant dynamic changes in these properties. It has not been common to study many of these 
properties due to either expense, time-required, and/or lack of tools. 
 These interconnected protein properties include subcellular localisation, interactions, turnover 
rate and post-translational modifications, among many others. 
 Without analysing many of these properties, we will achieve only a limited understanding of 
many crucial biological regulatory mechanisms that involve variation in protein properties. 
 The impact of proteomics on cell biology will be enhanced when we can predict 
interdependence of protein properties for each protein. For example, knowing that a protein 
with a certain modification, if localised in the cytosol, will be degraded. 
 Future innovations will allow more comprehensive measurement of a wider range of protein 
properties. 
 Data analysis and data sharing are critical to maximise the impact for cell biology of mass 
spectrometry based proteome-wide analyses. In particular, making such data available to cell 
biologists in free to access, web-based and graphically-rich formats will be important to 
leverage the full benefit of all the information being generated. 
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Preface 
The proteome is a dynamic system in which each protein displays interconnected properties — 
dimensions — that together contribute to cell phenotype. Measuring these properties has proved 
challenging owing to their diversity and dynamic nature. Advances in mass-spectrometry-based 
proteomics are now enabling the measurement of multiple properties for thousands of proteins, 
including their abundance, isoform expression, turnover rate, subcellular localization, post-translational 
modifications and interactions. Complementing these experimental developments are new data 
analysis, integration and visualisation tools and data-sharing resources. Together, these advances in the 
multi-dimensional analysis of the proteome are transforming our understanding of various cellular and 
physiological processes. 
 
Introduction  
Proteins form the structural fabric of cells and underpin all metabolic processes and regulatory 
mechanisms. A wide range of protein properties, including abundance levels, protein–protein 
interactions, post-translational modifications (PTMs), subcellular localization patterns and protein 
synthesis and degradation rates, are all highly dynamic and can change rapidly during the course of 
biological processes, such as cell proliferation, cell migration, endocytosis and development. 
Understanding protein structure–function relationships in cell biology, therefore, not only requires the 
identification of proteins, but also the detailed analysis of protein properties that constitute the 
dimensions of the proteome (Figure 1a).  
Until recently, studying the dynamic behaviour of the proteome has most often focused on the 
analysis of a single, main parameter, such as either protein abundance, or PTMs. For example, a recent 
analysis identified >30,000 distinct sites of phosphorylation
1
, whereas other studies have identified 
~19,000 sites of ubiquitylation on ~5,000 proteins
2
. While these are landmark studies, a limitation of 
such single dimension analyses is that much critical biological information is lost through the 
averaging of quantitative data from the different cellular pools of a protein.  
With this in mind new mass spectrometry (MS)-based proteomics approaches specifically aim 
to combine improvements in instrumentation and analytical procedures with experimental designs 
focused on annotating the proteome with high-resolution and multi-dimensional biological information. 
Thus multiple protein properties — for example, protein degradation, synthesis and turnover rates3-6 — 
are examined either in parallel, or sequentially, with other protein properties, such as subcellular 
localization, total protein abundance, tissue distribution
7, 8
 and protein isoforms or variants
4, 9-11
. Using 
these approaches we can distinguish pools of proteins that behave differently in separate subcellular 
compartments and/or cell-cycle stages, and so on (Figure 1b). 
Most mass spectrometry-based proteomics experiments to date have used the bottom-up 
workflow
12
, in which proteins are identified by detecting peptides generated after protease cleavage. 
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One downside of this method is that the peptides identified and quantified might not have all come 
from a single protein species. For example, the same peptide might have originated from multiple 
protein isoforms and/or from distinct functional pools of the same protein. This can potentially lead to 
incorrect conclusions if the data are interpreted as representing the behaviour of a single polypeptide in 
the cell, when in reality they correspond to an average value from two or more distinct polypeptide 
species with different characteristics. 
Multidimensional analysis of the proteome is now facilitated thanks to major improvements in 
the sensitivity and resolution of mass spectrometry instrumentation and associated advances in 
technologies for sample preparation and data analysis
13
. For example, mass spectrometry -based 
proteomics provides the ability to analyse a large fraction of the population of endogenous, untagged 
proteins in cells and organisms, avoiding the time, cost and technical limitations that are inherent to 
either the construction and analysis of large quantities of tagged proteins, or the generation of protein-
specific antibodies. No other current technologies come close to mass spectrometry in terms of 
combined throughput, sensitivity, dynamic range and speed of data acquisition. Such speed and 
sensitivity has, for example, facilitated the analysis of the whole proteome of an organism in less than 
24 hours
14, 15
. In addition, a mass spectrometer can enhance quantitative accuracy by identifying and 
quantifying many peptides from each protein in a single experiment, which is equivalent to performing  
independent measurements with many different antibodies to quantify each protein.  
Most studies have used one of three main methodologies for relative quantitation of samples: 
i.e. label-free
5, 16-18
; in vivo metabolic stable-isotope labelling (SILAC (stable isotope labelling by 
amino acids in cell culture)
19
, 
15
N-labelling
20
 and NeuCode SILAC
21
); or stable-isotope labelling using 
chemical tags that are covalently attached in vitro (dimethyl-labelling
22, 23
, tandem mass tags (TMT)
24
 
and isobaric tags for relative and absolute quantitation (iTRAQ)
25
; see Supplementary Information 
S1). Continued improvements in mass spectrometry methods have also increased the flexibility of 
analysis. In particular, the development of data-independent acquisition (DIA) strategies
26
 complement 
the widely used data-dependent acquisition methods that randomly sample the population of peptides 
injected into the mass spectrometer. An advantage of DIA strategies is the ability to systematically 
analyse the peptide population in an extract, allowing for a more consistent quantitative analysis across 
large numbers of samples. DIA has been used recently, for example, to characterize changes in the 
macrophage proteome in response to HIV infection
27
, the cyclin-dependent kinase 4 interactome
28
 and 
the plant Golgi apparatus
29
. 
Another burgeoning area of development in the proteomics field explores ways of improving 
the analysis, visualization and sharing of the resulting large single and multi-dimensional data sets. 
This extends beyond the need for archiving raw mass spectrometry data sets from the published 
literature, to finding better ways to share and integrate proteome-level information with other genomic 
and transcriptomic data sets and to make these data more accessible to the wider biological community. 
For example, online resources are being developed to visualise, via intuitive interfaces, data derived 
from complex time-dependent biological responses that may affect thousands of proteins. This 
facilitates interactive access to the data as well as providing new mechanistic insights into protein 
function, revealing how cells and organisms respond to stimuli at a system-wide level. Data integration 
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and sharing still presents significant challenges, however owing to both the highly multi-dimensional 
and dynamic nature of proteomes and the complexity of the tools needed to postulate biological 
mechanisms from these data.  
In this Review, we discuss recent advances in the multi-dimensional analysis of the proteome, 
focusing on biological dimensions of proteins, such as their subcellular localization, turnover, 
interaction partners, and post-translational modifications. We also discuss data analysis, sharing-
resources and data integration and visualization tools, and highlight how multi-dimensional proteomic 
analysis impacts our understanding of various cellular processes. 
 
Biological dimensions  
The importance of the multi-dimensional analysis of protein properties to understanding cell and tissue 
biology has been demonstrated in the study of a number of cellular processes. Many of these studies 
have been aided by developments in mass spectrometry-based analysis allowing higher sensitivity and 
a higher dynamic range of quantitation
30-33
. In addition, biochemical and cell biological fractionation 
such as either chromatography, or centrifugation-based separations, have, over the last decade, 
increased in efficiency and resolution. Thus, multiple separations can now more easily be combined for 
sequential, multi-dimensional proteome analysis (Table 1). 
 
Protein subcellular localization. A major influence on the function of a protein is its distribution 
within the cell. The localization of certain proteins can also affect the properties of others, such as their 
interactions (including with substrates), degradation rates and post-translational modifications. For 
example, in the absence of phosphorylation, the human forkhead box protein O1 (FOXO1) 
transcription factor is localized on chromatin, to either activate, or repress, transcription from specific 
genes
34, 35
; phosphorylation of FOXO1, however, sequesters it in the cytoplasm, where it interacts with 
14-3-3 proteins
36
 (among others) and is subject to an altered rate of degradation
37
. This paradigm has 
been observed for many individual proteins, highlighting the importance of analysing the proteome as a 
multi-dimensional system.  
The number of methods for the analysis of protein subcellular localisation in cells and tissues 
is large and diverse. Each method may have advantages or disadvantages, depending on cell or tissue 
type and/or the targets to be analysed. The subcellular fractionation methods most usually combined 
with mass spectrometry-based analysis include differential centrifugation and either equilibrium, or 
non-equilibrium gradient centrifugation. These techniques are used for either the isolation of specific 
organelles, or for protein correlation profiling (PCP; see below)
38
, detergent solubility fractionation
4
 
and endogenous biotin tagging
39
. The most common problem associated with any biochemical 
subcellular fractionation is the artefactual post-cell lysis redistribution of proteins to other fractions
40, 41
. 
This may occur either due to the large dilution of the cellular contents, to using a lysis buffer with non-
physiological salt concentration, to using inappropriate detergents or to aggressive cell lysis 
procedures. Such cross-contamination issues are hard to avoid, especially during proteome-wide 
analysis and it is likely comparing results from multiple methods in parallel will be necessary to 
generate an accurate picture of protein localization in vivo. Conversely, the use of endogenous biotin-
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tagging
39
, where cells express a biotin ligase enzyme tagged with a specific-subcellular localization 
signal, thus allowing the biotinylation and subsequent purification of the proteins within the target 
compartment, would avoid some of the problems of mis-localization during fractionation as the 
biotinylation occurs prior to cell lysis. Combined with more traditional biochemical fractionation, it can 
provide complementary information on the localisation of all proteins within a subcellular compartment 
of interest. 
The resolution and quantitative accuracy of PCP
38, 42
 can be enhanced through the use of in 
vitro chemical labelling of fractionated proteins, a strategy known as LOPIT (localization of organelle 
proteins by isotope tagging)
43
. Recently, the resolution of LOPIT has been expanded by using a larger 
number of isotope labelling reagents
44
. Such PCP methods have the power to differentiate large 
organelles, small intracellular vesicle populations and even large complexes, such as ribosomes, purely 
based on their density.  A key advantage of this approach is that it does not require any individual 
organelle or complex to be purified to homogeneity. In addition, it can be used to analyse proteins 
derived from any cell or tissue, without requiring metabolic incorporation of stable isotope labels into 
living cells or organisms. 
 A number of studies have now combined the proteome-wide analysis of protein subcellular 
localization with the analysis of other parameters, such as protein synthesis and degradation rates
3, 4, 45
, 
stress responses
46, 47
, cell type-specific expression
48
, post-translational modifications
49, 50
 and 
developmental stage
51
. These studies were able to identify cellular responses that would otherwise have 
been obscured without the separate subcellular compartment analysis. For example, the late 
endosomal/lysosomal adaptor and MAPK and MTOR activator 4 (LAMTOR4; also known as 
C7ORF59) protein was shown to be rapidly degraded in the cytosolic, but not in membrane-associated, 
nuclear or cytoskeletal fractions
4
. These data highlight the importance of the combined analysis of 
multiple protein properties to distinguish quantitative data derived from distinct pools of a cellular 
protein that behave differently. 
 
Protein turnover. The rate  of protein turnover is a combination of synthesis and degradation rates. The 
protein synthesis rate can be affected by many parameters, including mRNA abundance, localization 
and translation efficiency.  Protein degradation is typically controlled by different factors, one being 
subcellular localization. For example, mitochondrial proteins can be degraded by different pathways 
than cytosolic proteins
52
. Protein PTMs can also either trigger, or inhibit, protein degradation. This is 
demonstrated by the cell-cycle-dependent phosphorylation of cyclin E, which can trigger its ubiquitin-
dependent degradation
53
. By contrast, acetylation of lysine residues in a protein can block ubiquitin-
dependent degradation
54
.  
 Classic methods for measuring protein turnover, such as either pulse–chase radioactive 
labelling, or cycloheximide treatment to inhibit protein synthesis, have now been adapted for the 
analysis of protein turnover at the proteome-wide level and combined with the measurement of other 
protein properties, including subcellular localization
3, 4, 6, 45
, tissue distribution
55
 and/or protein–protein 
interactions
56
 (Figure 2). Recently many nuclear proteins were identified in rat tissues that were either 
very slowly degraded, or never degraded, in stark contrast to the degradation rate of most proteins in 
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many other subcellular compartments
6
. Such effects would have been difficult to observe without 
combining subcellular fractionation and protein turnover analysis. 
Previous studies have also identified many proteins that are unstable only in specific 
subcellular compartments. For example, free ribosomal proteins are rapidly degraded in the 
nucleoplasmic compartment, but when assembled into ribosomal subunits and exported to the 
cytoplasm, they acquire long half-lives
3, 45
. Such data may also provide clues to the mechanisms by 
which proteins are rapidly turned over.  For example, proteins that are rapidly depleted and are also 
found in the endoplasmic reticulum, golgi and endosomes are likely to either be secreted proteins, or 
else destined for degradation via the lysosome or ERAD pathways. In contrast, cytosolic or nuclear 
proteins that are rapidly depleted will likely be degraded by the various proteasome complexes. 
An interesting aspect to the property of protein turnover rate is that newly synthesised proteins 
must undergo many changes to become fully functional, including proper folding, and often post-
translational modifications and binding to interaction partners. However, the detection of newly 
synthesised proteins by mass spectrometry-based proteomics is challenging, because the pool of pre-
existing protein is much larger than the fraction of newly synthesised protein. Over the past few years, 
several groups have pioneered the use of amino acid mimetics, such as azido-homoalanine (AHA; 
which replaces methionine residues) for the analysis of newly synthesized proteins
57-61
. This amino 
acid can be fed to cells in short pulses, such that only newly synthesised proteins will contain it. The 
ability to easily purify proteins that have incorporated such mimetics from cell lysates, using bio-
orthogonal “click” reactions, can greatly improve the sensitivity and speed of analysis of newly 
synthesised proteins (Box 1). 
 
Protein interactions. Proteins do not usually function in isolation; most interact non-covalently with 
either other molecules of the same protein, or with other proteins. Given the large size of most 
metazoan proteomes, the systematic analysis of all protein–protein interactions taking place in a cell is 
a daunting task. In general, three mass spectrometry-based approaches exist for the global analysis of 
protein complexes and protein–protein interactions (Figure 3).  
The first and most widely used approach involves variations on the affinity pull-down 
(immunoprecipitation) strategy (Figure 3a). This isolates a specific protein (and its binding partners)  
either by using antibodies against the endogenous protein, or by ectopically expressing it, tagged with, 
for example, GFP or with short peptides (e.g. FLAG, Myc or HA), followed by immunoprecipitation 
using anti-tag antibodies
62
. Such approaches, in conjunction with high-throughput cDNA cloning 
strategies, have been used to examine protein complexes on a proteome-wide scale
63-67
. A significant 
advantage of these methods is the very high sensitivity that can be achieved for low abundance 
complexes. So far, however, studies using affinity approaches to analyse the global network of protein–
protein interactions have generally not been combined with measurement of other protein properties. 
This is in no small part owing to the time and costs of performing such analyses, which typically 
involve >10,000 pull-downs for even a single experimental condition. 
The second approach is in vivo proximity labelling (Figure 3b), for example based on the 
ectopic expression of a protein of interest fused to either a promiscuous biotin-ligase derived from 
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bacteria (the BioID method)
68
, or a peroxidase enzyme capable of activating biotin-phenol  (the APEX 
method)
39
. Once activated, the biotin is rapidly and covalently conjugated to nearby proteins via either 
lysines, or tyrosines, for BioID and APEX, respectively. This facilitates the subsequent enrichment of 
potential interacting proteins using streptavidin pull-down. Given the high affinity interaction between 
biotin and streptavidin, one advantage of this approach is that the streptavidin pull-down allows using 
stringent buffers and extensive washing to maximise the purity of the preparation. The proximity 
ligation approach has also been extended to study plasma membrane proteins exposed to the 
extracellular milieu.  This is performed by incubating intact cells with antibody-peroxidase conjugates 
that will specifically interact with a plasma membrane protein for the subsequent conjugation of biotin-
tyramide molecules to proximal proteins
69
. Nonetheless, such methods involve the targeted expression 
of the recombinant ligase and therefore are more suited to application in cell lines rather than for 
primary cells and tissues, owing to the relative ease of transfecting/infecting cell lines. 
The third approach for the analysis of global protein–protein interactions is based on 
variations of the technique known as protein correlation profiling
9, 70, 71
 (PCP) (Figure 3c). These 
techniques use either chromatography, or density gradient centrifugation to separate native protein 
complexes according to size, density, shape, charge and/or hydrophobicity. In this approach, cell 
extracts are isolated and fractionated under conditions designed to preserve protein–protein interactions 
within complexes. Fractions are then collected across the entire elution, or gradient profile, before 
being individually processed to generate peptides and analysed by liquid chromatography coupled 
online to tandem mass spectrometry (LC-MS/MS) to identify their constituent proteins. Protein elution 
(gradient) profiles can then be generated for each protein and compared to other profiles by 
computational clustering and other approaches to identify putative interacting proteins on the basis of 
similarities in their elution profiles.  
A potential advantage of the PCP approach is that hundreds to thousands of protein complexes 
can be analysed simultaneously and rapidly. Combined PCP– mass spectrometry approaches have been 
used to characterize the interactome of a number of cell lines in combination with other protein 
properties, or cellular states, such as protein isoforms, post-translational modifications
9
, or the 
activation of signalling cascades
71
. A recent study also demonstrated that combining multiple 
chromatographic separations can increase the resolution between different protein complexes
70
. A 
disadvantage of the PCP approach is that currently only soluble complexes, with interactions that are 
not significantly weakened by the buffers used, can be analysed. 
 The experimental approaches outlined above can predict that complexes contain certain 
proteins, but not whether they interact with each other directly, or indirectly. Such information can be 
generated instead by protein crosslinking experiments
72, 73
. Advances in crosslinking chemistry, mass 
spectrometry methods and data analysis tools
74
 have recently enabled the successful mapping of direct 
protein–protein75-77 and protein–RNA78 interactions. These data can also provide structural insight into 
the assembly of protein complexes, particularly when the three-dimensional structures of individual 
protein components are already known
79-82
. Nonetheless, considerable challenges must still be 
overcome for such crosslinking analyses to be performed on a scale approaching even remotely a 
proteome-wide level, not least because of the bioinformatics difficulty in identifying crosslinked 
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peptides using mass spectrometry fragmentation methods. This includes the difficulty of accurately 
estimating the false-discovery rate for the identification of each co-fragmented peptide sequence, which 
can be derived from any protein in the original crosslinked protein mixture. 
 
Protein post-translational modifications. PTMs constitute a key mechanism for influencing the 
properties of many proteins, such as turnover rate, localization and interactions. The modifications can 
be introduced into, and removed from, proteins in a very rapid manner to affect protein function. Most 
studies of the effect and roles of PTMs have concentrated on the analysis of a relatively small number 
of PTMs, such as the reversible phosphorylation of serine, threonine and tyrosine residues, or the 
acetylation or ubiquitylation of lysine residues. These studies have provided critical insights into the 
regulation of protein properties during fundamental processes, such as cell-cycle progression
83, 84
, and 
into signalling mechanisms that affect cellular pathways, such as the epidermal growth factor signalling 
cascade
85
. 
 The analysis of protein phosphorylation, acetylation, glycosylation and ubiquitination has 
been greatly facilitated by key developments in both peptide fractionation using column-based 
chromatography and affinity matrices able to pull-down modified peptides in batch formats
86
. Modified 
peptides may be significantly enriched compared to non-modified peptides in chromatographic 
separations based on charge (ion exchange chromatography such as strong anion exchange
87
), for 
example, due to the added negative charge of the phosphate group(s). Separations based on hydrophilic 
interactions, such as HILIC, are also able to enrich phosphorylated and certain other modified 
peptides
88
 due to the altered hydrophilicity provided by the modified residues. These separations are 
usually combined with batch-format affinity enrichment, for example, using acetyl-lysine-specific 
antibodies for acetylated peptides
89, 90
. Chemical probes are also being generated that can be 
incorporated into proteins instead of their normal modification group to facilitate the easy extraction of 
the modified protein, or peptide, using bio-orthogonal “Click” reactions91. For example, protein O-
GlcNAcylation may be studied using modified precursor metabolites, such as peracetylated N-
azidoacetyl-glucosamine, which can be included in cell culture media to be used by cells in the O-
GlcNAcylation of proteins
92
. 
Increasingly, PTM analysis has been combined with the analysis of other protein properties, 
such as protein-protein interactions
9, 93
, developmental stage
94
 and tissue distribution
95
. These extra 
separations have allowed the observation of proteins present in multiple complexes, but where the 
phosphorylated form of a protein is only found within one of these complexes
9
. Also, the same protein 
present in different tissues can vary greatly in the sites and stoichiometry of phosphorylation
95
. Such 
distinctions would have been difficult to disentangle without the extra levels of biological dimension 
separation. 
The crosstalk between different post-translational modifications is also important as each 
modification could be considered a new protein property. This is exemplified by the complex set of 
modifications that may be imparted to histones – sometime termed the histone code - in order to 
modulate chromatin function
96
. However, many other biological systems, such as signalling networks
97
 
and developmental pathways
98
, also display crosstalk between different modifications on the same 
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protein. Notably, recent methods facilitate the sequential analysis of peptide mixtures generated from 
the same sample that are altered by many different post-translational modifications
99
, thereby enabling 
more protein properties to be analysed and cross-correlated. 
 New evidence showing the importance of less well characterized PTMs, including 
citrullination of arginine
100
 and hydroxylation of proline
101
 residues, has also emerged. For example, 
citrullination of a single arginine residue on the H1 linker histone excludes it from chromatin 
interactions, ultimately leading to chromatin decondensation, thereby regulating pluripotency
100
. 
Hydroxylation of a specific proline residue on the centrosomal protein CEP192 (centrosomal protein of 
192 kDa) targets it for ubiquitylation and subsequent degradation; this is an important mechanism for 
regulating centrosomal duplication and consequently cell-cycle progression
101
. This is a similar role to 
that of targeted proline hydroxylation in the regulated degradation of the transcription regulator 
hypoxia-inducible factor 1α (HIF1α)102.  
In summary, the examples above highlight the multi-dimensional properties of proteins and 
show how they are highly interconnected and important for protein function.  
 
Data analysis and sharing 
As seen with the rapid expansion of genome and transcriptome data arising from technical 
advances in the instrumentation for high-throughput DNA and RNA sequencing, the current growth in 
the number of deep proteome studies means that the cell biology community needs consistent ways to 
process, analyse and share these large proteomic data sets. We review below some of the technologies 
and resources that are currently available for the analysis and sharing of proteomics data and discuss 
the potential biological insight that can be gained by using them.  
 
Processing software. A large range of both commercial and academic software tools have been 
developed for the analysis of raw mass spectrometry data files. The diversity of the software solutions 
partly reflects the rapidly expanding range of mass spectrometry methods in use, as well as the large 
variety of mass spectrometry instrumentation on the market. Examples of free-to-use software for mass 
spectrometry analysis that have become widely used in the cell biology community include the 
MaxQuant
16, 103, 104
, Skyline
105
, COMPASS
106
 and Census
107, 108
 packages. 
MaxQuant provides tools for label-free, SILAC-based and reporter-ion-based analyses, all within the 
same package. It includes both a search engine (Andromeda) for peptide identification and a range of 
tools for quantitation and statistical analysis. The upsurge in the popularity of strategies for the data-
independent acquisition-based analysis of protein samples has been aided by software tools that are 
able to extract quantitative information from such data sets, as exemplified by the Skyline package. 
Skyline allows for the analysis of selected reaction monitoring (SRM), DIA and many other data types. 
Meanwhile, the Census software
107, 108
 (and associated tools) provides an alternative, multifunctional 
package that, in particular, allows for the analysis of data sets derived from 
15
N-labelling experiments. 
The development of mass spectrometry instruments that can generate MS3-level quantitative reporter 
ion data in TMT/iTRAQ experiments (Supplementary Information S1) brings new analytical 
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challenges that have not yet been addressed in most of the non-commercial proteomics software tools.  
Nevertheless, both the COMPASS
106
 and MaxQuant software packages provide the capability for 
peptide identification and quantitation that include the ability to analyse MS3-level reporter-ion data.  
 
Data analysis. The shareware and open-source software packages described above, along with the 
many commercial software solutions that provide similar functionalities, typically provide tools 
specifically for the identification (and, in some cases, quantification) of peptides based on the analysis 
of raw mass spectrometry data. However, software tools are also needed for the downstream statistical 
evaluation of experimental data after peptides and proteins have been identified and quantified. For 
example, evaluating which proteins show the most significant change either in abundance, or in other 
properties in response to specific stimuli, or predicting protein–protein interactions on the basis of the 
co-elution of two proteins in a chromatography-based separation. A number of statistical analysis 
packages are available for these purposes, including SPSS and R
109
 with its associated Bioconductor
110
 
suite of tools for bioinformatics analysis. The free-to-use R program combines the ability to perform 
database, statistical and graphing functions and can handle very large multi-dimensional datasets. In 
addition, many biology-specific packages are available for R, such as pRoloc, which is a tool for the 
analysis of protein localisation using the protein correlation profiling approach
111
. One potential down-
side of statistical packages such as R however is that they have a significant learning curve before most 
cell biologists can take full advantage of the features offered. 
Creating a wider base of user-friendly tools, without such a steep learning curve, for the 
interactive analysis and integration of multi-dimensional data that is suitable for broad use in the cell 
biology community, is an important area for future development. Illustrative examples of such software 
packages are the SAINT
112
 package and ProHits
113
, each of which uses advanced statistical analysis to 
differentiate between true and false-positive interactors in immunoprecipitation and affinity pull-down 
studies. In addition, the ComplexQuant
114
 package, which provides a pipeline for the analysis of 
chromatography-based data for interaction analysis, also fulfils a specialised statistical analysis role to 
estimate probabilities that two proteins interact. 
 
Data visualisation and integration. While we propose in this review that a multi-dimensional view of 
protein-level properties is important for understanding protein function, there is also a great need to 
integrate these data with other information. For example, there is a wealth of pre-existing datasets that 
contain complementary information, such as genomic sequence variations, microRNA and mRNA 
abundance patterns and in-depth functional annotation of genes in the literature from “low-throughput” 
experiments, for example as provided by Gene Ontology terms. Integrating these diverse datasets 
requires user-friendly tools with informative graphical outputs suitable for subsequent publication. One 
example of such a resource is DAVID
115, 116
 (Database for Annotation, Visualization and Integrated 
Discovery), which can annotate user datasets with a large variety of stored prior-knowledge. DAVID’s 
prior knowledge includes Gene Ontology terms, transcription factor binding sites, disease association, 
protein interactions and cellular pathways, to name only a few. While these data are rich and each 
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association is strongly backed up by statistical evidence, there still is a need to improve built-in 
visualisation tools for the data output by DAVID. 
The Cytoscape
117
 platform is a useful tool that can provide integration of external databases 
with user datasets and output these analyses in rich graphical formats. Many groups have provided apps 
for use in Cytoscape (see apps.cytoscape.org), which facilitate multi-dimensional analysis of gene 
function. One such application is the GSEA
118
 (Gene Set Enrichment Analysis) software tool. GSEA 
enables statistical testing of the enrichment of any list of genes or proteins within a user dataset, based 
on quantified changes detected in an experiment, such as protein abundance. These data can be output 
from GSEA for rich visualisation in the Cytoscape app called EnrichmentMap
119
. Such visualisation 
can help the user to derive otherwise hidden biological meaning from their data. 
 
Data-sharing resources.  
Effective sharing of proteomics data that can be easily searched and accessed by the cell 
biology community, is another area where there is great scope for further development of resources. As 
part of the ProteomeXchange consortium, the Proteomics Identifications (PRIDE) database, which is 
managed by the European Bioinformatics Institute (EBI), currently provides a central resource for 
sharing raw mass spectrometry files from published proteomics experiments. The raw files can be 
freely downloaded and re-analysed. However, although this is useful, particularly to specialist mass 
spectrometry and bioinformatics groups, it is not a convenient way for most cell biologists to interact 
with large-scale proteomics data. Major challenges remain in providing the data outputs of multi-
dimensional proteomics experiments in convenient, searchable formats.  
To help meet this need, a growing number of curated, online databases now provide access to 
a range of processed proteomics data that can be searched and linked with information from other 
large-scale, online resources, such as DNA and RNA ‘omics’ data, metabolic pathway and 3D protein 
structure data (Table 2). We have recently introduced such a resource, the “Encyclopedia of Proteome 
Dynamics”4 to share our data with the community in a web-based and user-friendly interface 
(Supplementary Information S2a). These resources also include protein–protein interaction 
networks, as exemplified by the search tool for the retrieval of interacting genes/proteins (STRING) 
database
120
 (Box 2), and tissue-specific protein expression patterns in humans (Supplementary 
Information S2b), as determined both by mass spectrometry -based proteomics
7, 8
  and antibody-based 
detection
121, 122
. Table 2 summarizes some of the currently available online databases that provide cell 
biologists with access to proteome-wide information. A more widespread adoption of consistent, 
searchable formats for the sharing of proteomics data is required to make sure that published 
information is of maximum potential use for the cell biology community. The widespread use of 
consistent experimental metadata formats would also enhance the ability to compare data published by 
different groups and contribute to the establishment of integrated, multi-dimensional datasets that 
encompass information from many separate experiments and data sources
123
. 
As well as the need for new tools for the analysis of proteomics data, there is also a need for a 
laboratory information management system (LIMS) software better accustomed to proteomics 
experiments. This software could simplify the management and sharing of large-scale proteomics data 
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sets, including the incorporation of detailed and consistent metadata that are needed to facilitate 
comparisons between data sets.  
 
Conclusions 
We have described here the advent of new approaches that combine state-of-the-art proteomic 
and cell biology methods, which are now rendering a system-wide view of protein properties amenable 
to direct measurement and analysis. This includes improvements in the mass spectrometry-based 
methods used to identify and quantify peptides and their cognate proteins with high sensitivity and 
accuracy. Coupled with this are innovative methods to separate proteins, either from different cellular 
organelles, post-transnationally-modified states, or interaction networks, which in combination will 
facilitate mechanistic insight into protein function and regulation. Ultimately the combination of these 
cell biology methods with mass spectrometry analysis will yield vast volumes of data that need to be 
stored, analysed and presented to the community in a clear and interactive format. 
This new ability to evaluate a dynamic, multi-dimensional view of the proteome will not only 
be critical for enhancing our understanding of basic cellular physiology and regulation, but also 
important for future advances in medicine and drug development. Further improvements in mass 
spectrometry instrumentation also continue to make the underlying technologies easier to use and more 
cost-effective. Paired with this is the need for further co-development of data-handling/sharing tools 
that facilitate the convenient management, analysis and dissemination of these data. We predict a bright 
future for expanding the application of mass spectrometry-based proteomics methods to researchers in 
the cell biology community and anticipate that further advances in mass spectrometry -based multi-
dimensional proteomics will greatly influence all aspects of future cell biology experimentation.  
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Boxes 
Box 1. Azido-homoalanine (AHA) and click-chemistry. Feeding azido-homoalanine (AHA) to cells 
in short pulses results in the incorporation of this amino acid into proteins, replacing methionine 
(MET), and thus enables the labelling of newly synthesized proteins. The presence of the azide group 
in the side chain of this amino acid facilitates the covalent modification of AHA-containing proteins in 
vitro with affinity reagents that contain groups such as alkynes through cycloaddition (‘click’) 
reactions. Commonly, an affinity group such as biotin is covalently attached to the AHA, resulting in 
tagged proteins that can subsequently be enriched by streptavidin-mediated pull-down. 
 
Box 2. Adding Extra Dimensions to Proteome Data with the STRING database. The search tool 
for the retrieval of interacting genes/proteins [CE: The forward-slash is part of the official name; 
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please leave as is.] [Au: Please ignore the comment in green – it’s for the copy editors.] (STRING) 
database provides an extraordinary wealth of data derived from many protein databases and literature 
resources for the analysis of interactions (physical or genetic) between proteins. As an example, the 
proteins across organisms database (PaxDB), which enables the user to evaluate the abundance (in 
parts per million – ppm) of proteins from diverse organisms and tissues, is integrated with the 
STRING
120
 database. This allows the user to search for a protein of interest — the mouse acyl-CoA 
desaturase 1 (SCD1) in the example shown in the figure — and view its abundance measurements (left) 
in the context of the abundances of all proteins known to interact with it. In addition, STRING contains 
all the known gene ontology terms for each protein and in this case the proteins associated with the 
“metabolism” gene ontology term have been highlighted by blue nodes (right). Together, these data 
could provide clues to regulatory elements within a pathway and add value to the data provided by each 
database.  
 
Figure Legends 
Figure 1. Multi-dimensional proteome analysis of cells and tissues. a) Proteins can display many 
different properties (dimensions) that are either largely physically (green shaded area), chemically 
(orange shaded area) or biologically (grey shaded area) relevant. Shown here are some of the properties 
that we think are most important for cell biology research and those that need to be taken into 
consideration when developing new separation methods for multi-dimensional analysis. b) A series of 
stacked cubes is shown, each of which contains a discrete pool of proteomic data that corresponds to 
the value of each dimension (localization, cell cycle phase and turnover rate). For each cube (see blow-
ups) we can analyse other dimensions such as protein activity, total protein abundance and 
phosphorylation stoichiometry. Together these visually represent an approach for the multi-
dimensional analysis of protein data. The pink spheres inside the expanded cubes A and B represent a 
specific protein of interest that in the G1 phase of the cell cycle may exist in either the cytosol, or the 
nucleus, displaying fast and slow turnover rates, respectively. These different pools (cubes) of the same 
protein have different properties, including increased protein abundance, phosphorylation and activity 
in the nuclear pool (cube B) compared with the cytosolic pool (cube A). 
 
Figure 2. Methods for protein turnover analysis. Proteome-wide turnover is typically measured 
using one of the two approaches illustrated here. Method 1 involves pulse-labelling of amino acids 
using either isotope labelling by amino acids in cell culture (SILAC), or 
15
N-labelling. The cells start 
with proteins (stars) containing ‘light’ stable isotopes (brown) and for various periods of time are 
switched into media with a ‘heavy’ isotope that is stably incorporated into specifc amino acids and thus 
labels newly synthesise proteins.  Proteins with rapid turnover rates (here for example cytosolic 
proteins (a)) will rapidly incorporate high levels of the ‘heavy’ isotope, whereas protein pools that have 
slower turnover rates (from the membrane (b) and nucleus(c) in this example) will show slower rates of 
“heavy” isotope incorporation. The ratio between light and heavy labelled peptides, which can be 
extracted using mass spectrometry based analysis, is a measure of the rate of turnover for each peptide 
detected and thereby for each protein. Method 2 involves the use cycloheximide to block protein 
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synthesis in live cells for various periods of time. The comparison of protein abundance between 
untreated and treated cells allows a calculation of the depletion rate of a protein in the cells, which may 
occur either due to its degradation, secretion, or both. The comparison of protein abundances may use 
any quantitative mass spectrometry technique, such as label-free analysis and isobaric-tag labelling. For 
either Methods 1 or 2, the use of cellular fractionation (into subcellular compartments in this case) can 
greatly increase the information gained compared to the analysis of total cell lysates (d). The protein 
depicted here is effectively stable in the nuclear compartment (c), has a slow turnover rate in the 
membrane-associated pool (b) and a fast turnover rate in the cytosol (a). When total cell lysates are 
examined, such turnover differences can be masked by the pools of protein that are most abundant.  In 
this example, the fast turnover of the cytosolic pool masks the stable nuclear fraction when total cell 
lysates are examined. m/z is the mass to charge ratio of each peptide ion as measured by mass 
spectrometers. 
 
Figure 3. Approaches for the analysis of protein interactions. Three main approaches exist for 
unbiased analysis of protein-protein interactions.  
(a) The first approach, based on affinity pulldown and isolation, uses either specific antibodies to an 
endogenous protein, or a tagged version of a protein to specifically isolate the protein of interest and its 
interacting partners. Protein complexes are eluted for subsequent analysis by digestion and liquid 
chromatography followed by tandem mass spectrometry (LC-MS/MS), before statistical approaches are 
applied to identify specific (purple and blue circles) from non-specific (green circles) binding partners 
present in the eluted mixture.  
(b) The second approach is based on proximity labelling, where cell lines are constructed that 
ectopically express a protein of interest (blue circle) fused to either a promiscuous biotin ligase, or a 
peroxidase enzyme. These enzymes can then covalently transfer biotin labels (pink star) to proteins in 
close proximity (purple circle), which are potential interacting proteins. The cells can then be lysed and 
the biotinylated proteins specifically isolated using streptavidin-conjugated beads. Similar to the 
procedure described in (a), the isolated proteins are digested and analysed by LC-MS/MS, and 
statistical tests are applied to identify specific (blue and purple circles) versus non-specific label 
transfer or pull-down (green circles).  
(c) The third approach uses protein correlation profiling with various biochemical methods, such as 
chromatography and density gradient centrifugation, to separate endogenous protein complexes 
according to size, density, charge or hydrophobicity, assuming that interacting proteins will co-elute. 
This analysis may involve a single type of separation, or could involve multiple forms of separation, 
either sequentially, or in parallel. Following the collection of fractions from each separation, the 
digestion of proteins and their identification by LC-MS/MS analysis, an elution profile for each 
detected protein is generated and compared to that of other proteins. Clustering algorithms can then 
identify co-eluting proteins and infer the protein complexes in the lysate. Additional information can 
also be obtained such as the size or density of each identified complex.  
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Abbreviations: HIC, hydrophobic interaction chromatography; IEX, ion-exchange chromatography; 
LC-MS/MS, liquid chromatography – tandem mass spectrometry; SEC, size-exclusion 
chromatography. 
 
Table 1 – Analysing dimensions of the proteome 
 
Dimension Examples of techniques used 
Abundance 
(absolute and relative) 
Label-free quantitation
5, 16-18
; SILAC
19
; 
15
N-labelling
20
; NeuCode SILAC
21
; 
Dimethyl-labelling
22, 23
; TMT
24
; iTRAQ
25
 
Cell cycle regulation Centrifugal elutriation
124
; Chemical inhibitors of cell-cycle regulators
125
; 
FACS
126
 (for DNA content or phase-specific markers) 
Tissue distribution Dissection
95, 127
; FACS
126
 (for cell-type specific markers) 
Interactions Affinity-enrichment (endogenous IP or tagged fusion protein pull-down)
63-
67
; Protein correlation profiling
9, 70, 71
, Proximity-labelling
39, 68
 
Post-translational 
modifications 
Affinity enrichment (TiO2
128, 129
, IMAC
128, 130
, modification-specific 
antibodies
90, 131-133
); Chromatography (IEX
87
, HILIC
94
, ERLIC
134
) 
Localisation Centrifugation
3, 43, 135
, Affinity-enrichment; Protein correlation profiling
38, 44
; 
Proximity-labelling
39
, Detergent Solubility
4
. 
Turnover Metabolic pulse-labelling
3, 5, 6, 55
, cycloheximide treatment
4
. 
Isoform expression High sequence coverage to identify isoform-specific peptides. Typically 
achieved by peptide-level fractionation prior to LC-MS/MS using either ion-
exchange
136
, or high-pH reverse-phase
137
 chromatography. Alternatively, 
targeted MS analysis may be used to detect isoform-specific peptides. 
Solubility Thermal denaturation followed by differential centrifugation
138
 
Activity Analogue sensitive kinases
139
; activity-dependent binding domains
140
. 
Tertiary Structure Protease sensitivity
141
; Crosslinking
77, 78
. 
Abbreviations: FACS, Fluorescence-associated cell sorting; SILAC, stable isotope labelling by amino 
acids in cell culture; TMT, tandem mass tags; iTRAQ, isobaric tags for relative and absolute 
quantitation; IMAC, immobilised metal affinity chromatography; IEX, ion-exchange chromatography; 
HILIC, hydrophilic interaction chromatography; ERLIC, Electrostatic repulsion hydrophilic interaction 
chromatography. 
 
Table 2 - Data handling and sharing resources 
 
Resource Key features Strengths Comments 
 
Protein dimension annotation resources 
Encyclopedia of Proteome 
Dynamics (EPD)
4
 
peptracker.com/epd 
Graphical display of protein 
dimension data; diverse 
dimensions analysed 
Diverse dimensions 
analysed including 
multi-dimensional 
data sets. 
Single lab as 
source of data 
Human Protein Atlas
122
 
proteinatlas.org 
Proteomic annotation of 
protein abundance and 
localization 
High sensitivity; 
localisation is 
analysed within 
many tissues. 
Antibody-based; 
single lab as 
source of data; 
human data only 
Human Proteome Map
7
 
humanproteomemap.org 
Human proteome data 
annotated for tissue 
abundance 
Whole pathway or 
protein family 
analysis. 
One protein 
dimension; 
human data only 
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The MaxQuant Database 
(MaxQB)
142
 
maxqb.biochem.mpg.de/m
xdb 
Proteome data tabulated; 
graph for label-free 
abundance measurement 
Quality control 
parameters for mass 
spectrometry 
acquisition are 
presented. 
Single lab as 
source of data 
The Multi-Omics Profiling 
Expression Database 
(MOPED)
143
 
moped.proteinspire.org 
Allows search and 
visualizations of protein data 
derived from multiple 
species 
Many different 
experiments can be 
visualised and 
compared. 
Chromosome-
centric 
The proteins across 
organisms database 
(PaxDB)
144
 
pax-db.org 
Absolute protein abundance 
values determined across 
many organisms and tissues. 
Abundance 
histogram; STRING 
integration. 
Basic user 
interface 
Phosphorylation site 
database (Phosida)
145
 
www.phosida.com 
Provides data on 
phosphorylation, acetylation, 
and N-glycosylation of 
proteins; includes EGF-
treated, cell-cycle regulated, 
kinome-related data sets 
Diverse dimensions 
analysed with high 
depth of coverage 
for phosphorylation 
data sets. 
Single lab as 
source of data 
ProteomicsDB
8
 
https://www.proteomicsdb
.org 
Human proteome data 
annotated for tissue 
abundance; mass 
spectrometry spectra shown 
Tissue protein 
abundance pattern 
and mass 
spectrometry 
spectral annotation; 
Multi-protein 
analysis. 
Human data only 
 
Mass spectrometry -based raw proteomics data repositories 
Chorus 
chorusproject.org 
Offers storage, search and 
visualization of mass 
spectrometry -based 
proteomics data files 
Well-developed 
search and mass 
spectrometry data 
file visualization 
Limited public 
mass 
spectrometry data 
included 
Global Proteome Machine 
Database (GPMDB)
146, 147
 
gpmdb.thegpm.org 
Allows search and 
visualization of mass 
spectrometry data derived 
from many species 
Rich graphical 
interface for mass 
spectrometry data 
visualization 
MS2 spectral 
validation 
emphasized 
ProteomeXchange 
Consortium 
proteomexchange.org 
Includes: The Proteomics 
Identifications [PRIDE], 
PeptideAtlas, PeptideAtlas 
SRM Experiment Library 
[PASSEL], Mass 
spectrometry Interactive 
Virtual Environment 
[MassIVE]  
Allows centralized 
submission of mass 
spectrometry raw data and 
associated files for shotgun 
and targeted mass 
spectrometry analyses 
New interface for 
submission and 
download of data; 
managed by the EBI. 
Requires visiting 
consortium 
member sites for 
the visualization 
of mass 
spectrometry data 
files 
Abbreviations: EBI, European Bioinformatics Institute; EGF, epidermal growth factor; MS2, tandem 
mass spectrometry; SRM, selected reaction monitoring 
 
References  
1. Batth, T.S., Francavilla, C. & Olsen, J.V. Off-Line High-pH Reversed-Phase Fractionation for 
In-Depth Phosphoproteomics. J. Proteome Res. 13, 6176-6186 (2014). 
2. Kim, W. et al. Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome. 
Mol. Cell. 44, 325-340 (2011). 
3. Boisvert, F.O.M. et al. A Quantitative Spatial Proteomics Analysis of Proteome Turnover in 
Human Cells. Mol. Cell. Proteomics. 11, M111.011429 (2012). 
18 
 
4. Larance, M., Ahmad, Y., Kirkwood, K.J., Ly, T. & Lamond, A.I. Global Subcellular 
Characterization of Protein Degradation Using Quantitative Proteomics. Mol. Cell. 
Proteomics. 12, 638-650 (2013). 
5. Schwanhausser, B. et al. Global quantification of mammalian gene expression control. Nature. 
473, 337-342 (2011). 
6. Toyama, B.H. et al. Identification of Long-Lived Proteins Reveals Exceptional Stability of 
Essential Cellular Structures. Cell. 154, 971-982 (2013). 
7. Kim, M.S. et al. A draft map of the human proteome. Nature. 509, 575-81 (2014). 
8. Wilhelm, M. et al. Mass-spectrometry-based draft of the human proteome. Nature. 509, 582-
587 (2014). 
9. Kirkwood, K.J., Ahmad, Y., Larance, M. & Lamond, A.I. Characterization of Native Protein 
Complexes and Protein Isoform Variation Using Size-fractionation-based Quantitative 
Proteomics. Mol. Cell. Proteomics. 12, 3851-3873 (2013). 
10. Wu, L. et al. Variation and genetic control of protein abundance in humans. Nature. 499, 79-
82 (2013). 
11. Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 
513, 382-387 (2014). 
12. Yates, J.R., Ruse, C.I. & Nakorchevsky, A. Proteomics by Mass Spectrometry: Approaches, 
Advances, and Applications. Annual Review of Biomedical Engineering. 11, 49-79 (2009). 
13. Breker, M. & Schuldiner, M. The emergence of proteome-wide technologies: systematic 
analysis of proteins comes of age. Nat. Rev. Mol. Cell Bio. 15, 453-464 (2014). 
14. Hebert, A.S. et al. The One Hour Yeast Proteome. Mol. Cell. Proteomics. 13, 339-347 (2014). 
15. Kulak, N.A., Pichler, G., Paron, I., Nagaraj, N. & Mann, M. Minimal, encapsulated 
proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat. 
Methods. 11, 319-324 (2014). 
16. Cox, J. et al. MaxLFQ allows accurate proteome-wide label-free quantification by delayed 
normalization and maximal peptide ratio extraction. Mol. Cell. Proteomics. (2014). 
17. Silva, J.C., Gorenstein, M.V., Li, G.Z., Vissers, J.P. & Geromanos, S.J. Absolute 
quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. 
Proteomics. 5, 144-156 (2006). 
18. Ishihama, Y. et al. Exponentially modified protein abundance index (emPAI) for estimation of 
absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. 
Cell. Proteomics. 4, 1265-1272 (2005). 
19. Ong, S.E. et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and 
accurate approach to expression proteomics. Mol. Cell. Proteomics. 1, 376-386 (2002). 
20. Washburn, M.P., Ulaszek, R., Deciu, C., Schieltz, D.M. & Yates, J.R. Analysis of quantitative 
proteomic data generated via multidimensional protein identification technology. Anal. Chem. 
74, 1650-1657 (2002). 
21. Hebert, A.S. et al. Neutron-encoded mass signatures for multiplexed proteome quantification. 
Nat. Methods. 10, 332-334 (2013). 
22. Boersema, P.J., Raijmakers, R., Lemeer, S., Mohammed, S. & Heck, A.J.R. Multiplex peptide 
stable isotope dimethyl labeling for quantitative proteomics. Nat. Protoc. 4, 484-494 (2009). 
23. Hsu, J.L., Huang, S.Y., Chow, N.H. & Chen, S.H. Stable-isotope dimethyl labeling for 
quantitative proteomics. Anal. Chem. 75, 6843-6852 (2003). 
24. Thompson, A. et al. Tandem mass tags: A novel quantification strategy for comparative 
analysis of complex protein mixtures by MS/MS. Anal. Chem. 75, 1895-1904 (2003). 
25. Ross, P.L. et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-
reactive isobaric tagging reagents. Mol. Cell. Proteomics. 3, 1154-1169 (2004). 
26. Gillet, L.C. et al. Targeted Data Extraction of the MS/MS Spectra Generated by Data-
independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis. 
Mol. Cell. Proteomics. 11, O111.016717 (2012). 
27. Haverland, N.A., Fox, H.S. & Ciborowski, P. Quantitative Proteomics by SWATH-MS 
Reveals Altered Expression of Nucleic Acid Binding and Regulatory Proteins in HIV-1-
Infected Macrophages. J. Proteome Res. 13, 2109-2119 (2014). 
28. Lambert, J.P. et al. Mapping differential interactomes by affinity purification coupled with 
data-independent mass spectrometry acquisition. Nat. Methods. 10, 1239-1245 (2013). 
29. Nikolovski, N., Shliaha, P.V., Gatto, L., Dupree, P. & Lilley, K.S. Label free protein 
quantification for plant Golgi protein localisation and abundance. Plant Physiol. 166, 1033-
1043 (2014). 
19 
 
30. Ahrens, C.H., Brunner, E., Qeli, E., Basler, K. & Aebersold, R. Generating and navigating 
proteome maps using mass spectrometry. Nat. Rev. Mol. Cell Biol. 11, 789-801 (2010). 
31. Bensimon, A., Heck, A.J. & Aebersold, R. Mass spectrometry-based proteomics and network 
biology. Annu. Rev. Biochem. 81, 379-405 (2012). 
32. Richards, A.L., Merrill, A.E. & Coon, J.J. Proteome sequencing goes deep. Curr. Opin. Chem. 
Biol. 24C, 11-17 (2014). 
33. Walther, T.C. & Mann, M. Mass spectrometry-based proteomics in cell biology. J. Cell Biol. 
190, 491-500 (2010). 
34. Guo, S. et al. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by 
FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 
promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274, 17184-
17192 (1999). 
35. Rena, G., Guo, S., Cichy, S.C., Unterman, T.G. & Cohen, P. Phosphorylation of the 
transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 274, 
17179-17183 (1999). 
36. Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead 
transcription factor. Cell. 96, 857-868 (1999). 
37. Huang, H. et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated 
degradation. Proc. Natl. Acad. Sci. U.S.A. 102, 1649-1654 (2005). 
38. Andersen, J.S. et al. Proteomic characterization of the human centrosome by protein 
correlation profiling. Nature. 426, 570-574 (2003). 
39. Rhee, H.W. et al. Proteomic Mapping of Mitochondria in Living Cells via Spatially Restricted 
Enzymatic Tagging. Science. 339, 1328-1331 (2013). 
40. Press, M.F., Xu, S.H., Wang, J.D. & Greene, G.L. Subcellular-Distribution of Estrogen-
Receptor and Progesterone-Receptor with and without Specific Ligand. Am. J. Pathol. 135, 
857-864 (1989). 
41. Tinnikov, A.A. & Samuels, H.H. A Novel Cell Lysis Approach Reveals That Caspase-2 
Rapidly Translocates from the Nucleus to the Cytoplasm in Response to Apoptotic Stimuli. 
PloS one. 8 (2013). 
42. Foster, L.J. et al. A mammalian organelle map by protein correlation profiling. Cell. 125, 187-
199 (2006). 
43. Dunkley, T.P.J., Watson, R., Griffin, J.L., Dupree, P. & Lilley, K.S. Localization of organelle 
proteins by isotope tagging (LOPIT). Mol. Cell. Proteomics. 3, 1128-1134 (2004). 
44. Christoforou, A., Arias, A.M. & Lilley, K.S. Determining Protein Subcellular Localization in 
Mammalian Cell Culture with Biochemical Fractionation and iTRAQ 8-Plex Quantification. 
Shotgun Proteomics: Methods and Protocols. 1156, 157-174 (2014). 
45. Lam, Y.W., Lamond, A.I., Mann, M. & Andersen, J.S. Analysis of nucleolar protein dynamics 
reveals the nuclear degradation of ribosomal proteins. Curr. Biol. 17, 749-760 (2007). 
46. Baqader, N.O., Radulovic, M., Crawford, M., Stoeber, K. & Godovac-Zimmermann, J. 
Nuclear Cytoplasmic Trafficking of Proteins is a Major Response of Human Fibroblasts to 
Oxidative Stress. J. Proteome Res. 13, 4398-4423 (2014). 
47. Boisvert, F.M., Lam, Y.W., Lamont, D. & Lamond, A.I. A Quantitative Proteomics Analysis 
of Subcellular Proteome Localization and Changes Induced by DNA Damage. Mol. Cell. 
Proteomics. 9, 457-470 (2010). 
48. Ziegler, Y.S., Moresco, J.J., Tu, P.G., Yates, J.R., 3rd & Nardulli, A.M. Plasma membrane 
proteomics of human breast cancer cell lines identifies potential targets for breast cancer 
diagnosis and treatment. PloS one. 9, e102341 (2014). 
49. Hebert, A.S. et al. Calorie Restriction and SIRT3 Trigger Global Reprogramming of the 
Mitochondrial Protein Acetylome. Mol. Cell. 49, 186-199 (2013). 
50. Still, A.J. et al. Quantification of Mitochondrial Acetylation Dynamics Highlights Prominent 
Sites of Metabolic Regulation. J. Biol. Chem. 288, 26209-26219 (2013). 
51. McClatchy, D.B., Liao, L.J., Lee, J.H., Park, S.K. & Yates, J.R. Dynamics of Subcellular 
Proteomes During Brain Development. J. Proteome Res. 11, 2467-2479 (2012). 
52. Fischer, F., Hamann, A. & Osiewacz, H.D. Mitochondrial quality control: an integrated 
network of pathways. Trends Biochem. Sci. 37, 284-92 (2012). 
53. Koepp, D.M. et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 
ubiquitin ligase. Science. 294, 173-177 (2001). 
54. Choudhary, C., Weinert, B.T., Nishida, Y., Verdin, E. & Mann, M. The growing landscape of 
lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Bio. 15, 536-550 
(2014). 
20 
 
55. Claydon, A.J., Thom, M.D., Hurst, J.L. & Beynon, R.J. Protein turnover: Measurement of 
proteome dynamics by whole animal metabolic labelling with stable isotope labelled amino 
acids. Proteomics. 12, 1194-1206 (2012). 
56. Larance, M. et al. Characterization of MRFAP1 Turnover and Interactions Downstream of the 
NEDD8 Pathway. Mol. Cell. Proteomics. 11, M111.014407 (2012). 
57. Baboo, S. et al. Most human proteins made in both nucleus and cytoplasm turn over within 
minutes. PloS one. 9, e99346 (2014). 
58. Eichelbaum, K. & Krijgsveld, J. Rapid temporal dynamics of transcription, protein synthesis 
and secretion during macrophage activation. Mol. Cell. Proteomics. 13, 792-810 (2014). 
59. Liang, V. et al. Altered proteostasis in aging and heat shock response in C. elegans revealed 
by analysis of the global and de novo synthesized proteome. Cell. Mol. Life Sci. 71, 3339-
3361 (2014). 
60. Shen, W. et al. Acute synthesis of CPEB is required for plasticity of visual avoidance behavior 
in Xenopus. Cell reports. 6, 737-747 (2014). 
61. Zhang, J., Wang, J., Ng, S., Lin, Q. & Shen, H.M. Development of a novel method for 
quantification of autophagic protein degradation by AHA labeling. Autophagy. 10, 901-12 
(2014). 
62. Trinkle-Mulcahy, L. et al. Identifying specific protein interaction partners using quantitative 
mass spectrometry and bead proteomes. J. Cell Biol. 183, 223-239 (2008). 
63. Guruharsha, K.G. et al. A protein complex network of Drosophila melanogaster. Cell. 147, 
690-703 (2011). 
64. Gavin, A.C. et al. Functional organization of the yeast proteome by systematic analysis of 
protein complexes. Nature. 415, 141-7 (2002). 
65. Ho, Y. et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by 
mass spectrometry. Nature. 415, 180-3 (2002). 
66. Hubner, N.C. et al. Quantitative proteomics combined with BAC TransgeneOmics reveals in 
vivo protein interactions. J. Cell Biol. 189, 739-754 (2010). 
67. Jager, S. et al. Global landscape of HIV-human protein complexes. Nature. 481, 365-70 
(2012). 
68. Roux, K.J., Kim, D.I., Raida, M. & Burke, B. A promiscuous biotin ligase fusion protein 
identifies proximal and interacting proteins in mammalian cells. J. Cell Biol. 196, 801-810 
(2012). 
69. Li, X.W. et al. New Insights into the DT40 B Cell Receptor Cluster Using a Proteomic 
Proximity Labeling Assay. J. Biol. Chem. 289, 14434-14447 (2014). 
70. Havugimana, P.C. et al. A Census of Human Soluble Protein Complexes. Cell. 150, 1068-
1081 (2012). 
71. Kristensen, A.R., Gsponer, J. & Foster, L.J. A high-throughput approach for measuring 
temporal changes in the interactome. Nat. Methods. 9, 907-909 (2012). 
72. Schmidt, C. et al. Comparative cross-linking and mass spectrometry of an intact F-type 
ATPase suggest a role for phosphorylation. Nat. Commun. 4, 1985 (2013). 
73. Leitner, A., Walzthoeni, T. & Aebersold, R. Lysine-specific chemical cross-linking of protein 
complexes and identification of cross-linking sites using LC-MS/MS and the xQuest/xProphet 
software pipeline. Nat. Protoc. 9, 120-137 (2014). 
74. Fischer, L., Chen, Z.A. & Rappsilber, J. Quantitative cross-linking/mass spectrometry using 
isotope-labelled cross-linkers. J. Proteomics. 88, 120-128 (2013). 
75. Brodie, N.I., Makepeace, K.A., Petrotchenko, E.V. & Borchers, C.H. Isotopically-coded short-
range hetero-bifunctional photo-reactive crosslinkers for studying protein structure. J. 
Proteomics. doi: 10.1016/j.jprot.2014.08.012. (2014). 
76. Liu, F., Wu, C., Sweedler, J.V. & Goshe, M.B. An enhanced protein crosslink identification 
strategy using CID-cleavable chemical crosslinkers and LC/MS(n) analysis. Proteomics. 12, 
401-405 (2012). 
77. Weisbrod, C.R. et al. In vivo protein interaction network identified with a novel real-time 
cross-linked peptide identification strategy. J. Proteome Res. 12, 1569-1579 (2013). 
78. Kramer, K. et al. Photo-cross-linking and high-resolution mass spectrometry for assignment of 
RNA-binding sites in RNA-binding proteins. Nat. Methods. 11, 1064-1070 (2014). 
79. Bui, K.H. et al. Integrated structural analysis of the human nuclear pore complex scaffold. 
Cell. 155, 1233-1243 (2013). 
80. Greber, B.J. et al. Architecture of the large subunit of the mammalian mitochondrial ribosome. 
Nature. 505, 515-519 (2014). 
21 
 
81. Shi, Y. et al. Structural characterization by cross-linking reveals the detailed architecture of a 
coatomer-related heptameric module from the nuclear pore complex. Mol. Cell. Proteomics. 
13, 2927-2943 (2014). 
82. Shukla, A.K. et al. Visualization of arrestin recruitment by a G-protein-coupled receptor. 
Nature. 512, 218-222 (2014). 
83. Dephoure, N. et al. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. 
U.S.A. 105, 10762-10767 (2008). 
84. Olsen, J.V. et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site 
occupancy during mitosis. Sci. Signal. 3, ra3 (2010). 
85. Sharma, K. et al. Ultradeep Human Phosphoproteome Reveals a Distinct Regulatory Nature of 
Tyr and Ser/Thr-Based Signaling. Cell Rep. 8, 1583-1594 (2014). 
86. Larsen, M.R., Trelle, M.B., Thingholm, T.E. & Jensen, O.N. Analysis of posttranslational 
modifications of proteins by tandem mass spectrometry. Biotechniques. 40, 790-798 (2006). 
87. Wang, F.J. et al. Fractionation of phosphopeptides on strong anion-exchange capillary trap 
column for large-scale phosphoproteome analysis of microgram samples. J. Sep. Sci. 33, 
1879-1887 (2010). 
88. Alpert, A.J. Hydrophilic-Interaction Chromatography for the Separation of Peptides, Nucleic-
Acids and Other Polar Compounds. J. Chromatogr. 499, 177-196 (1990). 
89. Choudhary, C. et al. Lysine Acetylation Targets Protein Complexes and Co-Regulates Major 
Cellular Functions. Science. 325, 834-840 (2009). 
90. Kim, S.C. et al. Substrate and functional diversity of lysine acetylation revealed by a 
proteomics survey. Mol. Cell. 23, 607-618 (2006). 
91. Chuh, K.N. & Pratt, M.R. Chemical methods for the proteome-wide identification of 
posttranslationally modified proteins. Curr. Opin. Chem. Biol. 24C, 27-37 (2015). 
92. Hahne, H. et al. Proteome Wide Purification and Identification of O-GlcNAc-Modified 
Proteins Using Click Chemistry and Mass Spectrometry. J. Proteome Res. 12, 927-936 
(2013). 
93. Naegle, K.M., White, F.M., Lauffenburger, D.A. & Yaffe, M.B. Robust co-regulation of 
tyrosine phosphorylation sites on proteins reveals novel protein interactions. Mol. Biosyst. 8, 
2771-2782 (2012). 
94. Edwards, A.V.G., Edwards, G.J., Schwammle, V., Saxtorph, H. & Larsen, M.R. Spatial and 
Temporal Effects in Protein Post-translational Modification Distributions in the Developing 
Mouse Brain. J. Proteome Res. 13, 260-267 (2014). 
95. Huttlin, E.L. et al. A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression. 
Cell. 143, 1174-1189 (2010). 
96. Lee, J.S., Smith, E. & Shilatifard, A. The language of histone crosstalk. Cell. 142, 682-685 
(2010). 
97. Parker, B.L. et al. Structural basis for phosphorylation and lysine acetylation cross-talk in a 
kinase motif associated with myocardial ischemia and cardioprotection. J. Biol. Chem. 289, 
25890-906 (2014). 
98. Palmisano, G. et al. A Novel Method for the Simultaneous Enrichment, Identification, and 
Quantification of Phosphopeptides and Sialylated Glycopeptides Applied to a Temporal 
Profile of Mouse Brain Development. Mol. Cell. Proteomics. 11, 1191-1202 (2012). 
99. Mertins, P. et al. Integrated proteomic analysis of post-translational modifications by serial 
enrichment. Nat. Methods. 10, 634-637 (2013). 
100. Christophorou, M.A. et al. Citrullination regulates pluripotency and histone H1 binding to 
chromatin. Nature. 507, 104-108 (2014). 
101. Moser, S.C. et al. PHD1 Links Cell-Cycle Progression to Oxygen Sensing through 
Hydroxylation of the Centrosomal Protein Cep192. Dev. Cell. 26, 381-392 (2013). 
102. Semenza, G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE. 2007, cm8 (2007). 
103. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-
range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-
1372 (2008). 
104. Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. 
J. Proteome Res. 10, 1794-1805 (2011). 
105. MacLean, B. et al. Skyline: an open source document editor for creating and analyzing 
targeted proteomics experiments. Bioinformatics. 26, 966-968 (2010). 
106. Wenger, C.D., Phanstiel, D.H., Lee, M.V., Bailey, D.J. & Coon, J.J. COMPASS: A suite of 
pre- and post-search proteomics software tools for OMSSA. Proteomics. 11, 1064-1074 
(2011). 
22 
 
107. Park, S.K. et al. Census 2: isobaric labeling data analysis. Bioinformatics. 30, 2208-2209 
(2014). 
108. Park, S.K., Venable, J.D., Xu, T. & Yates, J.R., 3rd. A quantitative analysis software tool for 
mass spectrometry-based proteomics. Nat. Methods. 5, 319-322 (2008). 
109. R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for 
Statistical Computing, Vienna, Austria, 2014). 
110. Gentleman, R.C. et al. Bioconductor: open software development for computational biology 
and bioinformatics. Genome Biol. 5, 80 (2004). 
111. Gatto, L., Breckels, L.M., Wieczorek, S., Burger, T. & Lilley, K.S. Mass-spectrometry-based 
spatial proteomics data analysis using pRoloc and pRolocdata. Bioinformatics. 30, 1322-1324 
(2014). 
112. Choi, H. et al. SAINT: probabilistic scoring of affinity purification-mass spectrometry data. 
Nat. Methods. 8, 70-73 (2011). 
113. Liu, G. et al. ProHits: integrated software for mass spectrometry-based interaction proteomics. 
Nature Biotechnology. 28, 1015-7 (2010). 
114. Wan, C.H. et al. ComplexQuant: High-throughput computational pipeline for the global 
quantitative analysis of endogenous soluble protein complexes using high resolution protein 
HPLC and precision label-free LC/MS/MS. J. Proteomics. 81, 102-111 (2013). 
115. Huang, D.W., Sherman, B.T. & Lempicki, R.A. Bioinformatics enrichment tools: paths 
toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 
(2009). 
116. Huang, D.W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large 
gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009). 
117. Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular 
interaction networks. Genome Res. 13, 2498-2504 (2003). 
118. Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for 
interpreting genome-wide expression profiles. P. Natl. Acad. Sci. U.S.A. 102, 15545-15550 
(2005). 
119. Merico, D., Isserlin, R., Stueker, O., Emili, A. & Bader, G.D. Enrichment Map: A Network-
Based Method for Gene-Set Enrichment Visualization and Interpretation. PloS one. 5 (2010). 
120. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased 
coverage and integration. Nucleic Acids Res. 41, D808-D815 (2013). 
121. Fagerberg, L. et al. Analysis of the Human Tissue-specific Expression by Genome-wide 
Integration of Transcriptomics and Antibody-based Proteomics. Mol. Cell. Proteomics. 13, 
397-406 (2014). 
122. Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-
1250 (2010). 
123. Ahmad, Y. & Lamond, A.I. A perspective on proteomics in cell biology. Trends Cell Biol. 24, 
257-264 (2014). 
124. Ly, T. et al. A proteomic chronology of gene expression through the cell cycle in human 
myeloid leukemia cells. Elife. 3, e01630 (2014). 
125. Ly, T., Endo, A. & Lamond, A.I. Proteomic analysis of the response to cell cycle arrests in 
human myeloid leukemia cells. Elife. 4 (2015). 
126. Bernas, T., Gregori, G., Asem, E.K. & Robinson, J.P. Integrating cytomics and proteomics. 
Mol. Cell. Proteomics. 5, 2-13 (2006). 
127. Geiger, T. et al. Initial Quantitative Proteomic Map of 28 Mouse Tissues Using the SILAC 
Mouse. Mol. Cell. Proteomics. 12, 1709-1722 (2013). 
128. Engholm-Keller, K. et al. TiSH - a robust and sensitive global phosphoproteomics strategy 
employing a combination of TiO2, SIMAC, and HILIC. J. Proteomics. 75, 5749-5761 (2012). 
129. Larsen, M.R., Thingholm, T.E., Jensen, O.N., Roepstorff, P. & Jorgensen, T.J.D. Highly 
selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide 
microcolumns. Mol. Cell. Proteomics. 4, 873-886 (2005). 
130. Neville, D.C.A. et al. Evidence for phosphorylation of serine 753 in CFTR using a novel 
metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci. 6, 
2436-2445 (1997). 
131. Boisvert, F.M., Cote, J., Boulanger, M.C. & Richard, S. A proteomic analysis of arginine-
methylated protein complexes. Mol. Cell. Proteomics. 2, 1319-1330 (2003). 
132. Xu, G.Q., Paige, J.S. & Jaffrey, S.R. Global analysis of lysine ubiquitination by ubiquitin 
remnant immunoaffinity profiling. Nat. Biotechnol. 28, 868-U154 (2010). 
23 
 
133. Lamoliatte, F. et al. Large-scale analysis of lysine SUMOylation by SUMO remnant 
immunoaffinity profiling. Nat. Commun. 5 (2014). 
134. Alpert, A.J. Electrostatic repulsion hydrophilic interaction chromatography for isocratic 
separation of charged solutes and selective isolation of phosphopeptides. Anal. Chem. 80, 62-
76 (2008). 
135. Prior, M.J. et al. Quantitative proteomic analysis of the adipocyte plasma membrane. J. 
Proteome Res. 10, 4970-4982 (2011). 
136. Ritorto, M.S., Cook, K., Tyagi, K., Pedrioli, P.G.A. & Trost, M. Hydrophilic Strong Anion 
Exchange (hSAX) Chromatography for Highly Orthogonal Peptide Separation of Complex 
Proteomes. J. Proteome Res. 12, 2449-2457 (2013). 
137. Gilar, M., Olivova, P., Daly, A.E. & Gebler, J.C. Two-dimensional separation of peptides 
using RP-RP-HPLC system with different pH in first and second separation dimensions. J. 
Sep. Sci. 28, 1694-1703 (2005). 
138. Savitski, M.M. et al. Tracking cancer drugs in living cells by thermal profiling of the 
proteome. Science. 346, 55-+ (2014). 
139. Banko, M.R. et al. Chemical genetic screen for AMPKalpha2 substrates uncovers a network 
of proteins involved in mitosis. Mol. Cell. 44, 878-892 (2011). 
140. Zhang, C.C. et al. Development and Application of a Quantitative Multiplexed Small GTPase 
Activity Assay Using Targeted Proteomics. J. Proteome Res. 14, 967-976 (2015). 
141. Feng, Y.H. et al. Global analysis of protein structural changes in complex proteomes. Nat. 
Biotechnol. 32, 1036-+ (2014). 
142. Schaab, C., Geiger, T., Stoehr, G., Cox, J. & Mann, M. Analysis of High Accuracy, 
Quantitative Proteomics Data in the MaxQB Database. Mol. Cell. Proteomics. 11, 
M111.014068 (2012). 
143. Montague, E. et al. MOPED 2.5 - an integrated multi-omics resource: multi-omics profiling 
expression database now includes transcriptomics data. Omics. 18, 335-343 (2014). 
144. Wang, M. et al. PaxDb, a Database of Protein Abundance Averages Across All Three 
Domains of Life. Mol. Cell. Proteomics. 11, 492-500 (2012). 
145. Gnad, F., Gunawardena, J. & Mann, M. PHOSIDA 2011: the posttranslational modification 
database. Nucleic Acids Res. 39, D253-260 (2011). 
146. Craig, R., Cortens, J.P. & Beavis, R.C. Open source system for analyzing, validating, and 
storing protein identification data. J. Proteome Res. 3, 1234-1242 (2004). 
147. Shanmugam, A.K., Yocum, A.K. & Nesvizhskii, A.I. Utility of RNA-seq and GPMDB 
Protein Observation Frequency for Improving the Sensitivity of Protein Identification by 
Tandem MS. J. Proteome Res. 13, 4113-4119 (2014). 
 
 
 
